Addition of lateral ganglionic eminence to rat mesencephalic grafts affects fiber outgrowth but does not enhance function

Cell Transplantation

Volumn 6, Issue 3, 1997, Pages 277-286

  Emgård Mattson, Mia ^a,c   Karlsson, Jenny ^a   Nakao, Naoyuki ^a,b   Brundin, Patrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c LUND UNIVERSITY   (Sweden)

Author keywords

DARPP 32; Dopamine; Neural transplantation; Striatum

Indexed keywords

OXIDOPAMINE; PHOSPHOPROTEIN DARPP 32; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL SIZE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; FORELIMB; GRAFT SURVIVAL; MEDIAN EMINENCE; MESENCEPHALON; NERVE GRAFT; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; BRAIN TISSUE TRANSPLANTATION; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; ENZYME INHIBITORS; FEMALE; FETAL TISSUE TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MOVEMENT; NERVE TISSUE PROTEINS; NEURONS; OXIDOPAMINE; PHOSPHOPROTEINS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; SYMPATHOLYTICS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 0030977069     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0963-6897(97)00038-9     Document Type: Article

References (48)

1. Abercrombie, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:239-247; 1946.
2. Abrous, D.N.; Shaltot, A.R.A.; Torres, E.M.; Dunnett, S.B. Dopamine-rich grafts in the neostriatum and/or nucleus accumbens: Effects on drug-induced behaviours and skilled paw-reaching. Neuroscience 53:187-197; 1993.
3. Abrous, D.N.; Torres, E.M.; Dunnett, S.B. Dopaminergic grafts implanted into the neonatal or adult striatum: Comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood. Neuroscience 54:657-668; 1993.
4. Björklund, A.; Lindvall, O. Dopamine-containing systems in the CNS. In: Björklund, A.; Hökfelt, T., eds. Handbook of chemical neuroanatomy, vol. 2: Classical transmitters in the CNS. Part I. New York: Elsevier; 1984:55-122.
5. Brundin, P.; Isacson, O.; Björklund, A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:251-259; 1985.
6. Brundin, P.; Isacson, O.; Gage, F.H.; Björklund A. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: Effects of mixing with target or non-target cells. Dev. Brain Res. 24:77-84; 1986.
7. Brundin, P.; Barbin, G.; Strecker, R.E.; Isacson, O.; Prochiantz, A.; Bjorklund, A. Survival and function of dissociated dopamine neurones grafted at different developmental stages or after being cultured in vitro. Dev. Brain Res. 39:233-243; 1988.
8. Brundin, P.; Strecker, R.E. Preparation and intracerebral grafting of dissociated fetal brain tissue in rats. In: Conn, P.M., ed. Methods in neuroscience. Vol. 8. New York: Academic Press; 1991: 305-326.
9. Brundin, P.; Duan, W.-M.; Sauer, H. Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. In: Dunnett, S.B.; Bjorklund, A., eds. Functional neural transplantation. New York: Raven Press; 1994:9-46.
10. Costantini, L.C.; Vozza, B.M.; Snyder-Keller, A.M. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: An anatomical and behavioral analysis. Exp. Neurol. 127:219-231; 1994.
11. Daguet, M.-C.; di Porzio, U.; Prochiantz, A.; Kato, A.; Glowinsky, J. Release of dopamine from dissociated mesencephalic dopaminergic neurons in primary cultures in absence or presence of striatal target cells. Brain Res. 191: 564-568; 1980.
12. de Beaurepaire, R.; Freed, W.J. Embryonic substantia nigra grafts innervate embryonic striatal co-grafts in preference to mature host striatum. Exp. Neurol. 95:448-454; 1987.
13. Denis-Donini, S.; Glowinski, J.; Prochiantz, A. Specific influence of striatal target neurons on the in vitro out-growth of dopaminergic neurites: A morphological quantitative study. J. Neurosci. 3:2292-2299; 1983.
14. di Porzio, U.; Daguet, M.-C.; Glowinski, J.; Prochiantz, A. Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature 288:370-373; 1980.
15. Dong, J.F.; Delta, A.; Bakker, M.H.M.; Hitchcock, E.R. Direct interaction with target-derived glia enhances survival but not differentiation of human fetal mesencephalic dopaminergic neurons. Neuroscience 56:53-60; 1993.
16. Dunnett, S.B.; Whishaw, I.Q.; Rogers, D.C. Jones, G.H. Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxy-dopamine lesions. Brain Res. 415:63-78; 1987.
17. German, D.C.; Schlusselberg, D.S.; Woodward, D.J. Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: From mouse to man. J. Neural Transm. 57:243-254; 1983.
18. Graybiel, A.M.; Liu, F.C.; Dunnett, S.B. Intrastriatal grafts derived from fetal striatal primordia. I. phenotype and modular organization. J. Neurosci. 9:3250-3271; 1989.
19. Hemmendinger, L.M.; Garber, B.B.; Huffman, P.C.; Heller, A. Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro. Proc. Natl. Acad. Sci. USA 78:1264-1268; 1981.
20. Hoffman, P.C.; Hemmendinger, L.M.; Kotake, C.; Heller, A. Enhanced dopamine cell survival in reaggregates containing telencephalic target cells. Brain Res. 274:275-281; 1983.
21. Jaeger, C.B. Axon terminal clustering in nigrostriatal double grafts. Dev. Brain Res. 24:309-314; 1986.
22. Kordower, J.H.; Rosenstein, J.M.; Collier, T.J.; Burke, M.A.; Chen, E.-Y.; Li, J.M.; Martel, L.; Levey, A.E.; Mufson, E.J.; Freeman, T.B.; Olanow, C.W. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370:203-230; 1996.
23. Lindvall, O. Neural transplantation in Parkinson's disease. In: Dunnett, S.B.; Björklund, A., eds. Functional neural transplantation. New York: Raven Press 1994:103-137.
24. Mayer, E.; Fawcett, J.W.; Dunnett, S.B. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons-II. Effects on nigral transplants in vivo. Neuroscience 56:389-398; 1993.
25. Mayer, C.H.A.; Delta, A.; Kudoh, C. Hitchcock's experimental series of foetal implants for Parkinson's disease: Co-grafting ventral mesencephalon and striatum. Adv. Stereotact. Funct. Neurosurg. 11:1-4; 1996.
26. Montoya, C.D.; Astell, S.; Dunnett, S.B. Effects of nigral and striatal grafts on skilled forelimb use in the rat. Prog. Brain Res. 82:459-466; 1990.
27. Montoya, C.D.; Campbell, H.L.; Pemberton, K.D.; Dunnett, S.B. The "staircase test": A measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods 36:219-228; 1991.
28. Nakao, N.; Frodl, E.M.; Duan, W.-M.; Widner, H.; Brundin, P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA 91:12408-12412; 1994.
29. Nakao, N.; Odin, P.; Brundin, P. Selective sub-dissection of the striatal primordium for the cultures affects the yield of DARPP-32-containing neurons. Neuroreport 5:1081-1084; 1994.
30. Nakao, N.; Frodl, E.M.; Widner, H.; Carlson, E.; Eggerding, F.A.; Epstein, C.J.; Brundin, P. Overexpressing Cu/Zn Superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1:226-231; 1995.
31. Nakao, N.; Brundin, P. Effects of α-phenyl-tert-butylnitrone on neuronal survival and motor function following intrastriatal injections of quinolinic or 3-nitropropionic acid. Neuroscience 76:749-761; 1997.
32. Nakao, N.; Grasbon-Frodl, E.M.; Widner, H.; Brundin, P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw-reaching in an animal model of Huntington's disease. Neuroscience 74:959-970; 1996.
33. Nikkhah, G.; Duan W.-M.; Knappe, U.; Jödicke, A.; Björklund, A. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model. Neuroscience 56:33-43; 1993.
34. Olanow, C.W.; Kordower, J.H.; Freeman, T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19:102-109; 1996.
35. Olsson, M.; Cambell, K.; Wictorin, K.; Björklund, A. Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence. Neuroscience 69:1169-1182; 1995.
36. Ouimet, C.C.; Miller, P.E.; Hemmings, H.C., Jr.; Walaas, S.I.; Greengard, P. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4:111-124; 1984.
37. Pakzaban, P.; Deacon, T.W.; Burns, L.H.; Isacson, O. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp. Brain Res. 97:13-22; 1993.
38. Prochiantz, A.; di Pozio, U.; Kato, A.; Berger, B.; Glowinski, J. In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc. Natl. Acad. Sci. USA 76:5387-5391; 1979.
39. Prochiantz, A.; Daguet, M.-C.; Herbet, A.; Glowinsky, J. Specific stimulation of in vitro maturation of mesencephal-ic dopaminergic neurones by striatal membranes. Nature 293:570-572; 1981.
40. Rosenblad, C.; Martinez-Serrano, A.; Björklund, A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 75:979-985; 1996.
41. Sauer, H.; Brundin, P. Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Rest. Neurol. Neurosci. 2:123-135; 1991.
42. Sauer, H.; Frodl, E.M.; Kupsch, A.; ten Bruggencate, G.; Oertel, W.H. Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease. Exp. Brain Res. 90:54-62; 1992.
43. Shalaby, I.A.; Hoffman, P.C.; Heller, A. Release of dopamine from mesencephalic neurons aggregate cultures: Influence of target and non-target cells. Brain Res. 307:347-350; 1984.
44. Takayama, H.; Ray, J.; Raymon, H.K.; Baird, A.; Hogg, J.; Fisher, L.J.; Gage, F.H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat. Med. 1:53-58; 1995.
45. Tomozawa, Y.; Appel, S.H. Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain Res. 399:111-124; 1986.
46. Ungerstedt, U.; Arbuthnott, G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine systems. Brain Res. 24:485-493; 1970.
47. Whishaw, I.Q.; O'Connor, T.; Dunnett, S.B. The contributions of motor cortex, nigrostriatal dopamine and caudateputamen to skilled forelimb use in the rat. Brain 109:805-843; 1985.
48. Yurek, D.M.; Collier, T.J.; Sladek, J.R., Jr. Embryonic mesencephalic and striatal co-grafts: Development of grafted dopamine neurons and functional recovery. Exp. Neurol. 109:191-199; 1990.